Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP736161.RASCNEGrV6ZI8944fRYiv5_sPHpgxR503vEXYolXxUwSc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP736161.RASCNEGrV6ZI8944fRYiv5_sPHpgxR503vEXYolXxUwSc130_assertion type Assertion NP736161.RASCNEGrV6ZI8944fRYiv5_sPHpgxR503vEXYolXxUwSc130_head.
- NP736161.RASCNEGrV6ZI8944fRYiv5_sPHpgxR503vEXYolXxUwSc130_assertion wasGeneratedBy ECO_0000203 NP736161.RASCNEGrV6ZI8944fRYiv5_sPHpgxR503vEXYolXxUwSc130_provenance.
- NP736161.RASCNEGrV6ZI8944fRYiv5_sPHpgxR503vEXYolXxUwSc130_assertion wasDerivedFrom befree-20140225 NP736161.RASCNEGrV6ZI8944fRYiv5_sPHpgxR503vEXYolXxUwSc130_provenance.
- NP736161.RASCNEGrV6ZI8944fRYiv5_sPHpgxR503vEXYolXxUwSc130_assertion SIO_000772 11337506 NP736161.RASCNEGrV6ZI8944fRYiv5_sPHpgxR503vEXYolXxUwSc130_provenance.
- NP736161.RASCNEGrV6ZI8944fRYiv5_sPHpgxR503vEXYolXxUwSc130_assertion evidence source_evidence_literature NP736161.RASCNEGrV6ZI8944fRYiv5_sPHpgxR503vEXYolXxUwSc130_provenance.
- NP736161.RASCNEGrV6ZI8944fRYiv5_sPHpgxR503vEXYolXxUwSc130_assertion description "[We employed a retroviral infection approach to stably express transdominant (TD) mutants of IkappaBalpha, IkappaBbeta, or IkappaBepsilon and dominant negative (dn) versions of IkappaB kinases (IKK) 1 or 2 as well as a constitutively active version of IKK2 in human endothelial cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736161.RASCNEGrV6ZI8944fRYiv5_sPHpgxR503vEXYolXxUwSc130_provenance.